Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)

Journal of the American College of Cardiology

Volumn 63, Issue 19, 2014, Pages 2007-2013

  Chrispin, Jonathan ^a   Jain, Aditya ^a   Soliman, Elsayed Z ^b   Guallar, Eliseo ^c   Alonso, Alvaro ^d   Heckbert, Susan R ^e   Bluemke, David A ^f   Lima, João A C ^a   Nazarian, Saman ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

atrial fibrillation; cardiac magnetic resonance imaging; electrocardiography; left ventricular hypertrophy

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOKOLOW LYON VOLTAGE PRODUCT; AGE DISTRIBUTION; AGED; CLINICAL CLASSIFICATION; COHORT ANALYSIS; HYPERTENSION; OBESITY; PREVALENCE; PROGNOSIS;

ATRIAL FIBRILLATION; CARDIAC MAGNETIC RESONANCE IMAGING; ELECTROCARDIOGRAPHY; LEFT VENTRICULAR HYPERTROPHY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED;

EID: 84900541976     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.066     Document Type: Article

References (38)

1. T. Lewis Report CXIX. Auricular fibrillation: a common clinical condition Br Med J 2 1909 1528
2. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
3. A.D. Krahn, J. Manfreda, R.B. Tate, F.A. Mathewson, and T.E. Cuddy The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study Am J Med 98 1995 476 484
4. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 2002 359 364
5. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
6. H. Watanabe, N. Tanabe, and Y. Makiyama et al. ST-segment abnormalities and premature complexes are predictors of new-onset atrial fibrillation: the Niigata preventive medicine study Am Heart J 152 2006 731 735
7. S.M. Vaziri, M.G. Larson, E.J. Benjamin, and D. Levy Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study Circulation 89 1994 724 730
8. P. Verdecchia, G. Reboldi, and R. Gattobigio et al. Atrial fibrillation in hypertension: predictors and outcome Hypertension 41 2003 218 223
9. J.R. Kizer, J.N. Bella, and V. Palmieri et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS) Am Heart J 151 2006 412 418
10. N.G. Bellenger, M.I. Burgess, and S.G. Ray et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 21 2000 1387 1396
11. P.B. Bottini, A.A. Carr, L.M. Prisant, F.W. Flickinger, J.D. Allison, and J.S. Gottdiener Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient Am J Hypertens 8 1995 221 228
12. A.A. Malayeri, W.C. Johnson, R. Macedo, J. Bathon, J.A. Lima, and D.A. Bluemke Cardiac cine MRI: quantification of the relationship between fast gradient echo and steady-state free precession for determination of myocardial mass and volumes J Magn Reson Imaging 28 2008 60 66
13. F. Grothues, G.C. Smith, and J.C. Moon et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34
14. B.E. Bild, D.A. Bluemke, and G.L. Burke et al. Multi-Ethnic Study of Atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881
15. S. Natori, S. Lai, and J.P. Finn et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity AJR Am J Roentgenol 186 Suppl 2 2006 S357 S365
16. A. Jain, H. Tandri, and D. Dalal et al. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J 159 2010 652 658
17. M. Sokolow, and T.P. Lyon The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads Am Heart J 37 1949 161 186
18. P.N. Casale, R.B. Devereux, D.R. Alonso, E. Campo, and P. Kligfield Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings Circulation 75 1987 565 572
19. D.W. Romhilt, and E.H. Estes Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy Am Heart J 75 1968 752 758
20. G. Schillaci, P. Verdecchia, and C. Borgioni et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy Am J Cardiol 74 1994 714 719
21. P. Verdecchia, F. Angeli, and G. Reboldi et al. Improved cardiovascular risk stratification by a simple ECG index in hypertension Am J Hypertens 16 2003 646 652
22. R.J. Prineas, R.S. Crow, and H. Blackburn The Minnesota Code Manual of Electrocardiographic Findings 1982 John Wright-PSG Littleton, MA
23. T. Lewis Observations upon ventricular hypertrophy with special reference to preponderance of one or the other chamber Heart 5 1914 367 402
24. J.E. Norman Jr., D. Levy, G. Campbell, and J.J. Bailey Improved detection of echocardiographic left ventricular hypertrophy using a new electrocardiographic algorithm J Am Coll Cardiol 21 1993 1680 1686
25. P.M. Okin, M.J. Roman, R.B. Devereux, and P. Kligfield Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products J Am Coll Cardiol 25 1995 417 423
26. B.P. Hsieh, M.X. Pham, and V.F. Froelicher Prognostic value of electrocardiographic criteria for left ventricular hypertrophy Am Heart J 150 2005 161 167
27. P.M. Rautaharju, L.P. Park, J.S. Gottdiener, D. Siscovick, R. Boineau, V. Smith, and N.R. Powe Race- and sex-specific ECG models for left ventricular mass in older populations: factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans J Electrocardiol 33 2000 205 218
28. D. Pewsner, P. Jüni, M. Egger, M. Battaglia, J. Sundström, and L.M. Bachmann Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review BMJ 335 2007 711
29. D. Levy, S.B. Labib, K.M. Anderson, J.C. Christiansen, W.B. Kannel, and W.P. Castelli Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy Circulation 81 1990 815 820
30. P.M. Okin, M.J. Roman, R.B. Devereux, J.S. Borer, and P. Kligfield Electrocardiographic diagnosis of left ventricular hypertrophy by time-voltage integral of the QRS complex J Am Coll Cardiol 23 1994 133 140
31. L. Bacharova, H. Estes, and L. Bang et al. The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy J Electrocardiol 43 2010 197 199
32. A. Ducharme, K. Swedberg, M.A. Pfeffer for the CHARM Investigators Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Am Heart J 152 2006 86 92
33. K. Wachtell, M. Lehto, and E. Gerdts et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study J Am Coll Cardiol 45 2005 712 719
34. R.E. Schmieder, S.E. Kjeldsen, S. Julius for the VALUE Trial Group Reduced incidence of new-onset atrial brillation with angiotensin II receptor blockade: the VALUE trial J Hypertens 26 2008 403 411
35. A.P. Maggioni, R. Latini, P.E. Carson for the Val-HeFT Investigators Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT) Am Heart J 149 2005 548 557
36. J.S. Healey, A. Baranchuk, and E. Crystal et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis J Am Coll Cardiol 45 2005 1832 1839
37. M.P. Schneider, T.A. Hua, M. Böhm, K. Wachtell, S.E. Kjeldsen, and R.E. Schmieder Prevention of atrial fibrillation by renin-angiotensin system inhibition: a meta-analysis J Am Coll Cardiol 55 2010 2299 2307
38. C. Cuspidi, M.L. Muiesan, L. Valagussa for the CATCH Investigators Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the Candesartan Assessment in the Treatment of Cardiac Hypertrophy (CATCH) study J Hypertens 20 2002 2293 2300